KEPPRA
Generic: LEVETIRACETAM
UCBManufacturer
ORALRoute
LEVETIRACETAMActive Substance
1999-11-30Original Approval
KEPPRA is FDA application NDA021035, sponsored by UCB INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Top Reported Reactions
1
SEIZURE
15,961 reports
2
DRUG INEFFECTIVE
12,292 reports
3
OFF LABEL USE
9,497 reports
4
FATIGUE
5,581 reports
5
SOMNOLENCE
4,171 reports
6
EPILEPSY
4,135 reports
7
CONVULSION
4,081 reports
8
FALL
3,757 reports
9
HEADACHE
3,728 reports
10
MATERNAL EXPOSURE DURING PREGNANCY
3,725 reports